Herpes zoster and postherpetic neuralgia: incidence and risk indicators using a general practice research database
Open accessThe DOI matches its Crossref record.
Abstract
BACKGROUND: Postherpetic neuralgia (PHN) is a frequent complication of herpes zoster (HZ). Treatment results of this severe and long-lasting pain syndrome are often disappointing. From the point of view of possible prevention and early treatment, it is important to identify HZ patients who have an increased risk of developing PHN. OBJECTIVES: Our goals were to determine the incidence of HZ and PHN in a primary care population and to identify risk indicators for the occurrence of PHN. METHODS: A search for HZ and PHN was conducted in a general practice research database, comprising 22 general practices and representing 49 000 people, over a 5-year period. Potential risk indicators were analysed using multivariate logistic regression. RESULTS: A total of 837 patients had been diagnosed with HZ [incidence 3.4/1000 patients/year, 95% confidence interval (CI) 2.9-3.9]. The risk of developing PHN 1 month after the start of the zoster rash was 6.5% (95% CI 4.9-8.3). This risk was 11.7% (95% CI 8.5-14.9) for patients aged > or =55 years. Independent risk indicators for the occurrence of PHN were age [55-74 years, adjusted odds ratio (OR) 4.2, 95% CI 1.8-9.7; >75 years, OR 10.7, 95% CI 4.6-25.1] and ophthalmic localization (OR 2.3, 95% CI 1.0-4.6). CONCLUSIONS: The risk of developing PHN increases with age. Preventive strategies should focus on patients with herpes zoster aged >55 years and with ophthalmic localization.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Neuropathic pain in the general population: A systematic review of epidemiological studies
van Hecke, O., Austin, S. K., Khan, R. A., Smith, B. H., & Torrance, N. (2014) · Pain · doi:10.1016/j.pain.2013.11.013 · Cited by 1,602
Systematic review of incidence and complications of herpes zoster: towards a global perspective
Kawai, K., Gebremeskel, B. G., & Acosta, C. J. (2014) · BMJ Open · doi:10.1136/bmjopen-2014-004833 · Cited by 938
Yawn, B. P., Saddier, P., Wollan, P. C., Sauver, J. L. S., Kurland, M. J., & Sy, L. S. (2007) · Mayo Clinic Proceedings · doi:10.4065/82.11.1341 · Cited by 867
What does epidemiology tell us about risk factors for herpes zoster?
Thomas, S. L., & Hall, A. J. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(03)00857-0 · Cited by 561
The incidence of herpes zoster in a United States administrative database
Insinga, R. P., Itzler, R. F., Pellissier, J. M., Saddier, P., & Nikas, A. A. (2005) · Journal of General Internal Medicine · doi:10.1111/j.1525-1497.2005.0150.x · Cited by 490
The impact of herpes zoster and post-herpetic neuralgia on quality-of-life
Johnson, R. W., Bouhassira, D., Kassianos, G., Leplège, A., Schmader, K. E., & Weinke, T. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-37 · Cited by 404
A systematic review and meta-analysis of risk factors for postherpetic neuralgia
Forbes, H. J., Thomas, S. L., Smeeth, L., Clayton, T., Farmer, R., Bhaskaran, K., & Langan, S. M. (2016) · Pain · doi:10.1097/j.pain.0000000000000307 · Cited by 355
Lewis, J. D., Bilker, W. B., Weinstein, R. B., & Strom, B. L. (2005) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1115 · Cited by 341
Johnson, R. W., Alvarez-Pasquin, M.-J., Bijl, M., Franco, E., Gaillat, J., Clara, J. G., Labetoulle, M., Michel, J.-P., Naldi, L., Sanmarti, L. S., et al. (2015) · Therapeutic Advances in Vaccines · doi:10.1177/2051013615599151 · Cited by 288
Epidemiology and cost of herpes zoster and post-herpetic neuralgia in the United Kingdom
GAUTHIER, A., BREUER, J., CARRINGTON, D., MARTIN, M., & RÉMY, V. (2009) · Epidemiology and Infection · doi:10.1017/s0950268808000678 · Cited by 287
Jumaan, A. O., Yu, O., Jackson, L. A., Bohlke, K., Galil, K., & Seward, J. F. (2005) · The Journal of Infectious Diseases · doi:10.1086/430325 · Cited by 285
Epidemiology of Neuropathic Pain and Its Impact on Quality of Life
Smith, B. H., & Torrance, N. (2012) · Current Pain and Headache Reports · doi:10.1007/s11916-012-0256-0 · Cited by 268
Quantification of risk factors for herpes zoster: population based case-control study
Forbes, H. J., Bhaskaran, K., Thomas, S. L., Smeeth, L., Clayton, T., & Langan, S. M. (2014) · BMJ · doi:10.1136/bmj.g2911 · Cited by 267
A systematic literature review of herpes zoster incidence worldwide
van Oorschot, D., Vroling, H., Bunge, E., Diaz-Decaro, J., Curran, D., & Yawn, B. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2020.1847582 · Cited by 249
McGreevy, K., Bottros, M. M., & Raja, S. N. (2011) · European Journal of Pain Supplements · doi:10.1016/j.eujps.2011.08.013 · Cited by 246
“The natural history leading to PHN begins with symptoms arising from acute herpes zoster (HZ) infection, which includes numbness, itching and pain during the prodromal phase, followed by painful unilateral vesicular eruptions on the skin lasting for approximately 3–4 weeks (Opstelten et al., 2002).”
Bouhassira, D., Chassany, O., Gaillat, J., Hanslik, T., Launay, O., Mann, C., Rabaud, C., Rogeaux, O., & Strady, C. (2012) · Pain · doi:10.1016/j.pain.2011.10.026 · Cited by 163
“Consistent with previous studies, zoster-related pain was associated with marked reductions in HRQoL in the acute phase [6,9,11,23,26,33,34,41], and also in patients with persistent pain [6,9,11,28,35,38,39,41].”
Result
Metadata
- Authors
- Opstelten, W.
- Venue
- Family Practice
- Publisher
- Oxford University Press (OUP)
- Published
- 2002-10-01
- Volume
- 19
- Issue
- 5
- Pages
- 471-475
- ISSN
- 0263-2136 (ISSN-L)
- 1460-2229
- OpenAlex
- W2148882495
- Cited by
- 228
- References
- 0
- FWCI
- 3.56
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.